Welcome to LookChem.com Sign In|Join Free

CAS

  • or

145943-75-5

Post Buying Request

145943-75-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

145943-75-5 Usage

Derivative of

Piperazine and propanol

Pharmacological properties

Serotonin receptor agonist

Potential use

Ingredient in pharmaceutical formulations

Industry interest

Pharmaceutical and chemical industries

Check Digit Verification of cas no

The CAS Registry Mumber 145943-75-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,9,4 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 145943-75:
(8*1)+(7*4)+(6*5)+(5*9)+(4*4)+(3*3)+(2*7)+(1*5)=155
155 % 10 = 5
So 145943-75-5 is a valid CAS Registry Number.

145943-75-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[4-(3-hydroxypropyl)piperazin-1-yl]ethanone

1.2 Other means of identification

Product number -
Other names 1-Piperazinepropanol,4-acetyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:145943-75-5 SDS

145943-75-5Relevant articles and documents

KRAS G12C INHIBITORS

-

Paragraph 0916-0917, (2019/05/24)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

NEW ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS AND USES IN TREATMENTS OF OBESITY AND DIABETES MELLITUS - 087

-

Page/Page column 243, (2009/07/25)

The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), or an enantiomer thereof, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, E, L, Z and n are as defined herein, to processes for preparing such compounds, to pharmaceutical compositions containing them, to the use of such inhibitors and to methods for th eir therapeutic use, particularly in the treatments of obesity and diabetes mellitus.

8-CHLORO AND 8-METHYLTHIO DERIVATIVES OF 10-PIPERAZINO-10,11-DIHYDRODIBENZOTHIEPINS; NEW COMPOUNDS AND NEW PROCEDURES

Jilek,Jiri,Pomykacek, Josef,Prosek, Zdenek,Holubek, Jiri,Svatek, Emil,et al

, p. 906 - 927 (2007/10/02)

The resolution of racemic clorothepin (Ia) was repeated and the water-soluble methanesulfonates of (S)(+)-clorothepin and (R)(-)-clorothepin were prepared which were used in recent studies of the stereoselectivity of action of this neuroleptic agent.Alkylation of the secondary amine VIa with 2-chloroethyl decanoate resulted in noroxyclothepin decanoate IVa whose basically catalyzed ethanolysis afforded smoothly the amino alcohol IIa.Reactions of amines VIa and VIb with 1,2-butene oxide gave the amino alcohols VIIab.Alkylation of the amine VIa with 5-bromopentan-2-oneand the following reduction of the amino ketone IXa formed gave the amino alcohol VIIIa.Amino alcohols IIa and IIIb were transformed by treatment with thionyl chloride to the chloroalkylamines Xa and XIb which were used for the synthesis of mandelates XIIa, XIIIb and benzilates XIVa, XVb derived from noroxyclothepin IIa and oxyprothepin IIIb.A substitution reaction of 2,11-dichloro-10,11-dihydrodibenzothiepin with 1,4-diazabicyclononane led to the clorothepin analogue XVI.From 2-chlorodibenzothiepin-10(11 H)-one XVII via the 11-bromo derivative XVIII the amino ketone XIX was prepared.While its reduction with sodium borohydride gave the cis-amino alcohol XXI, the reduction with diborane gave the trans-amino alcohol XXII.The pharmacological properties of the new piperazine derivatives are described; some of them showed a high degree of neuroleptic activity of various profile.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 145943-75-5